Use of tyrosine kinase inhibitors for treating inflammatory diseases
US7741335B2 · kind B2 · utility
0Cited by
19References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 28, 2002 |
| Grant date | Jun 22, 2010 |
| Priority date | — |
| Expiry date | Dec 28, 2022 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/70596
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a method for treating inflammatory diseases such as rheumatoid arthritis (RA), comprising administering a tyrosine kinase inhibitor to a human in need of such treatment, more particularly a non-toxic, selective and potent c-kit inhibitor. Preferably, said inhibitor is unable to promote death of IL-3 dependent cells cultured in presence of IL-3.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.